Company news

Harmony Biosciences Holdings, Inc. news in 2021

Harmony Biosciences Holdings, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Harmony Biosciences to be Added to the Nasdaq Biotech Index

December 16, 2021

Harmony Biosciences Publishes Pitolisant Efficacy Data In CNS Drugs

December 12, 2021

Harmony Biosciences Announces Plans To Initiate Phase 3 Clinical Trial For Treatment Of Idiopathic Hypersomnia

November 30, 2021

Harmony Biosciences Appoints Linda Szyper To Its Board Of Directors

November 21, 2021

Harmony Biosciences To Participate In Two Investor Conferences In November

November 10, 2021

Harmony Biosciences Reports Third Quarter 2021 Financial Results and Business Updates

November 8, 2021

Harmony Biosciences Announces Date of Third Quarter 2021 Financial Results

October 25, 2021

Harmony Biosciences Announces Winners of Patients at the Heart and Progress at the Heart on Third Annual World Narcolepsy Day

September 21, 2021

Harmony Biosciences To Participate In Three Investor Conferences In September

September 1, 2021

Harmony Biosciences Announces Inclusion Of WAKIX® (pitolisant) In American Academy Of Sleep Medicine's Updated Clinical Practice Guideline

September 1, 2021

Harmony Biosciences Reports Second Quarter 2021 Financial Results and Business Updates

August 9, 2021

Harmony Biosciences And Blackstone Enter Into Strategic Financing Collaboration

August 9, 2021

Harmony Biosciences Acquires Asset With Novel Mechanism Of Action For The Potential Treatment Of Narcolepsy And Other Rare Neurological Diseases

August 8, 2021

John C. Jacobs, President And CEO Of Harmony Biosciences, Named An Ernst & Young (EY) Entrepreneur Of The Year 2021 Greater Philadelphia Award Winner

July 28, 2021

Harmony Biosciences Announces Date Of Second Quarter 2021 Financial Results

July 26, 2021

Harmony Biosciences Initiates A Phase 2 Clinical Trial In Myotonic Dystrophy

June 28, 2021

Correction: Harmony Biosciences

June 9, 2021

Harmony Biosciences Announces Applications for 2021 Patients At The Heart Grant Program Open June 9

June 8, 2021

Harmony Biosciences To Present New Data Analyses For WAKIX® (pitolisant) At The SLEEP 2021 Annual Meeting

June 6, 2021

Harmony Biosciences to Participate in Three Investor Conferences in June

May 25, 2021

John C. Jacobs, President and CEO of Harmony Biosciences, Joins Life Sciences Pennsylvania Board of Directors

May 17, 2021

Harmony Biosciences to Present at the Oppenheimer Rare and Orphan Disease Summit

May 17, 2021

Harmony Biosciences Reports First Quarter 2021 Results and Business Updates

May 10, 2021

Harmony Biosciences To Present WAKIX® (pitolisant) Efficacy and Safety Data at Upcoming 2021 American Psychiatric Association Annual Meeting

April 26, 2021

Harmony Biosciences Announces Date of First Quarter 2021 Financial Results

April 26, 2021

Harmony Biosciences To Present WAKIX® (Pitolisant) Data At The 2021 AAN Annual Meeting

April 11, 2021

Harmony Biosciences Launches Grant Program To Address Inequities In The Delivery Of Healthcare In Patients With Sleep Disorders

April 6, 2021

Harmony Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Business Updates

March 24, 2021

Harmony Biosciences Hosts Summit Which Sheds Light on Impact of Sleep Disruption in Rare Diseases

March 18, 2021

Harmony Biosciences Highlights Publication of WAKIX® (pitolisant) Efficacy Data in Sleep Medicine

March 16, 2021

Harmony Biosciences Appoints Sandip Kapadia as Chief Financial Officer

March 14, 2021

Harmony Biosciences Announces Date Of Fourth Quarter And Full Year 2020 Financial Results

March 3, 2021

Harmony Biosciences Certified As A Great Place To Work For The Third Year In A Row

March 1, 2021

Calls in 2021

Decks in 2021